Advanced Medical Isotope Corporation Engages Barry Kaplan Associates to Enhance Financial Market

company logo

KENNEWICK, Wash., June 20, 2013 (GLOBE NEWSWIRE) -- Advanced Medical Isotope Corporation (OTCBB:ADMD) today announced that it has retained the services of Barry Kaplan Associates ("BKA"), of Fair Haven, New Jersey to enhance financial market relations. BKA has agreed to assist Advanced Medical Isotope Corporation by preparing background documentation regarding the company and arranging for investor and media presentations, with monthly meetings to increase awareness of Advanced Medical Isotope Corporation in the financial marketplace.

BKA is owned by Barry Kaplan. Mr. Kaplan and BKA have been providing investor relations services to publicly traded companies for more than 30 years.

James C. Katzaroff, CEO & Founder, commented, "We are very pleased to be represented by Barry Kaplan and his company, as we continue to build awareness of Advanced Medical Isotope Corporation within the financial and investment communities."

Advanced Medical Isotope Corporation is a Washington State based company comprised of a brilliant team of radio-chemists, scientists and engineers, collaborating with national labs and universities to implement proprietary technologies capable of producing crucial medical isotopes on US soil.

By enabling physicians and empowering researchers to find isotope solutions, we are helping to lengthen the lives of Cancer patients and creating hope for a healthier future.

The Advanced Medical Isotope Corporation logo is available at

Safe Harbor Statement

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by the use of the words "may," "will," "should," "plans," "expects," "anticipates," "continue," "estimates," "projects," "intends," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, AMIC's ability to successfully execute its expanded business strategy, including by entering into definitive agreements with suppliers, commercial partners and customers; general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technical advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, regulatory requirements and the ability to meet them, government agency rules and changes, and various other factors beyond the Company's control.

CONTACT: Press Contact: Barry S. Kaplan Company Contact: James C. Katzaroff CEO & Founder Tel: (509) 736-4000 Website:

Source:Advanced Medical Isotope Corporation